이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

SaiGon - Hanoi Securities 관리

관리 기준 확인 1/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Nguyen Thanh

최고 경영자

n/a

총 보상

CEO 급여 비율	n/a
CEO 임기	no data
CEO 소유권	n/a
경영진 평균 재임 기간	데이터 없음
이사회 평균 재임 기간	9.5yrs

최근 관리 업데이트

Recent updates

CEO

Nguyen Thanh (44 yo)

no data

테뉴어

Mr. Nguyen Chi Thanh had been Deputy General Director since May 05, 2014 and serves as its General Director and served as its Head of Ho Chi Minh City Office at Saigon - Hanoi Securities Joint Stock Compan...

이사회 구성원

이름	위치	테뉴어	보상	소유권
Khoa Le	Director	11.3yrs	데이터 없음	0% ₫ 0
Tien Vu	Vice President of the Board	9.8yrs	데이터 없음	데이터 없음
Luu Luong	Supervisory Board Member	9.3yrs	데이터 없음	데이터 없음
Hong Pham	Head of Supervisory Board	16.5yrs	데이터 없음	데이터 없음
Trung Vu	Supervisory Board Member	12.3yrs	데이터 없음	0.33% ₫ 46.9b
Trinh Nguyen	Independent Director	4.5yrs	데이터 없음	0% ₫ 0
Vinh Do	Chairman of the Board	2.3yrs	데이터 없음	1.54% ₫ 220.0b
Duc Luu	Director	2.3yrs	데이터 없음	데이터 없음

9.5yrs

평균 재임 기간

47yo

평균 연령

경험이 풍부한 이사회: SHS 의 이사회는 경험(평균 재직 기간 9.5 년)으로 간주됩니다.

SaiGon - Hanoi Securities 관리

관리 기준 확인 1/4

주요 정보

최근 관리 업데이트

Less than half of directors are independent

Less than half of directors are independent

Recent updates

New minor risk - Share price stability

Full year 2023 earnings released: EPS: ₫688 (vs ₫238 in FY 2022)

Investor sentiment deteriorates as stock falls 16%

Full year 2023 earnings released: EPS: ₫966 (vs ₫221 in FY 2022)

Investor sentiment deteriorates as stock falls 22%

Third quarter 2023 earnings released: EPS: ₫245 (vs ₫138 in 3Q 2022)

Investor sentiment deteriorates as stock falls 17%

Second quarter 2023 earnings released: EPS: ₫173 (vs ₫494 loss in 2Q 2022)

First quarter 2023 earnings released: EPS: ₫50.00 (vs ₫810 in 1Q 2022)

Now 20% undervalued

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Less than half of directors are independent

Investor sentiment deteriorated over the past week

Third quarter 2022 earnings released: EPS: ₫172 (vs ₫906 in 3Q 2021)

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Investor sentiment deteriorated over the past week

Now 27% undervalued after recent price drop

Saigon - Hanoi Securities Joint Stock Company (HNX:SHS) acquired additional 5.9% minority stake in Pharmedic Pharmaceutical Medicinal Joint Stock Company (HNX : PMC).

Now 20% undervalued after recent price drop

Investor sentiment deteriorated over the past week

Less than half of directors are independent

Investor sentiment deteriorated over the past week

First quarter 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment deteriorated over the past week

Full year 2021 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Third quarter 2021 earnings released: EPS ₫1,132 (vs ₫642 in 3Q 2020)

Investor sentiment deteriorated over the past week

Inaugural dividend of ₫1,200 per share

Investor sentiment improved over the past week

Second quarter 2021 earnings released: EPS ₫1,496 (vs ₫1,059 in 2Q 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

First quarter 2021 earnings released: EPS ₫1,307 (vs ₫225 in 1Q 2020)

Investor sentiment deteriorated over the past week

Full year 2020 earnings released: EPS ₫3,639

Investor sentiment improved over the past week

New 90-day high: ₫26,800

New 90-day high: ₫20,600

Investor sentiment improved over the past week

New 90-day high: ₫15,500

New 90-day high: ₫13,800

Third quarter earnings released

New 90-day high: ₫13,700

CEO

테뉴어

이사회 구성원

평균 재임 기간

평균 연령